Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:33 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 417 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Diabetic Ulcers Clear all

Conditions: Diabetic Foot Ulcer
Interventions: Noveon laser; Device
Lead sponsor: Nomir Medical Technologies; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Diabetic Ulcer of Plantar Aspect of Left Foot, Diabetic Ulcer of Plantar Aspect of Right Foot, Diabetic Polyneuropathy
Interventions: nerve decompression; Procedure
Lead sponsor: Association of Extremity Nerve Surgeons; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 6
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 3 more

Conditions: Diabetic Foot Ulcer
Interventions: DermACELL, GraftJacket, Conventional Care Dressings; Other
Lead sponsor: LifeNet Health; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 12
States / cities: Montgomery, Alabama • Tucson, Arizona • Carlsbad, California + 8 more

Conditions: Pressure Ulcer, Venous Ulcer, Diabetic Ulcer, Surgical Wound, Trauma Wound
Interventions: PuraPly™ Antimicrobial Wound Matrix; Device
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Foot Ulcer, Diabetic
Interventions: GrafixPRIME®, Dressing Application, Off-loading (walking boot); Other · Procedure · Device
Lead sponsor: Osiris Therapeutics; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Arizona City, Arizona • California City, California • New Mexico, New Mexico

Conditions: Diabetic Foot Ulcer, Diabetic Foot
Interventions: Lifestyle-based intervention by an occupational therapist; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 21 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetic Foot, Ulcer Foot, Wound Heal
Interventions: Wound debridement, Wound closure matrix application; Procedure · Device
Lead sponsor: Polymedics Innovations Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Circleville, Ohio

Conditions: Diabetic Foot Ulcer, Diabetic Neuropathy, Type 2 Diabetes
Interventions: Diabetic Foot Ulcer Biopsy, Survey, Comprehensive Neuropathy Assessment, Wound Photography; Procedure · Other
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Diabetic Foot Ulcers
Interventions: MEBO Wound Ointment (MEBO), Standard of Care; Drug · Other
Lead sponsor: Skingenix, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 9
States / cities: Phoenix, Arizona • Castro Valley, California • Encinitas, California + 6 more

Conditions: Diabetic Foot Ulcer
Interventions: GrafixPL PRIME; Biological
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetic Foot Ulcer
Interventions: Kerecis Omega3 Wound, Fibracol; Device
Lead sponsor: Kerecis Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 5
States / cities: Coconut Creek, Florida • Smyrna, Georgia • Carmel, Indiana + 2 more

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer
Interventions: Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers, Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers, AmnioExcel Plus for Venous Leg Ulcers, AmnioExcel Plus for Diabetic Foot Ulcers, Standard of Care; Device · Procedure
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 13
States / cities: Los Angeles, California • San Francisco, California • Vista, California + 9 more

Conditions: Diabetic Foot Ulcer
Interventions: NuShield; Other
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 9
States / cities: Carlsbad, California • Fresno, California • Los Angeles, California + 6 more

Conditions: Diabetes
Interventions: debridement, dressing, and APC; Device
Lead sponsor: Harvest Technologies; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 9
States / cities: Fayetteville, Alaska • Orlando, Florida • St. Petersburg, Florida + 6 more

Conditions: Wounds, Diabetes Complications, Diabetic Foot, Foot Ulcer
Interventions: Online Wound Electronic Medical Record; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 1,609 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 13
States / cities: Phoenix, Arizona • Tuscon, Arizona • Pomona, California + 8 more

Conditions: Diabetic Foot Ulcer, Ulcer Foot, Diabetic Foot
Interventions: Mirragen Advanced Wound Matrix, Fibracol; Device
Lead sponsor: ETS Wound Care, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 15
States / cities: Los Angeles, California • Pomona, California • San Francisco, California + 12 more

Conditions: Diabetic Foot Ulcer
Interventions: Placenta Stem Cells; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Diabetic Foot Ulcers (DFUs), Diabetic Foot, Chronic Wounds
Interventions: Miro3D Wound Matrix, Standard of Care; Device · Other
Lead sponsor: Reprise Biomedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 14
States / cities: Phoenix, Arizona • Coconut Creek, Florida • Coral Gables, Florida + 9 more

Conditions: Chronic Diabetic Foot Ulcers
Interventions: 5% Bisphosphocin Topical Gel, Placebo Topical Gel, 10% Bisphosphocin Topical Gel; Drug
Lead sponsor: Lakewood-Amedex Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 5
States / cities: Jonesboro, Arkansas • Fresno, California • South Miami, Florida + 2 more

Conditions: Diabetic Foot Ulcer (DFU)
Interventions: FoundationDRS Solo, Standard of Care; Other
Lead sponsor: Samaritan Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Hollywood, Florida

Conditions: Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Wound, Diabetic
Interventions: Observational; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 418 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 6
States / cities: San Francisco, California • Stanford, California • Miami, Florida + 3 more

Conditions: Diabetic Foot Ulcer, Offloading
Interventions: Offloading boot: PulseFlow; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetic Complications
Interventions: Prontosan, Saline; Device
Lead sponsor: B. Braun Medical Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 2
States / cities: San Diego, California • Chicago, Illinois

Conditions: Diabetic Foot Ulcers
Interventions: DSC127, placebo vehicle gel, Standard of Care gel, Aquasite; Drug
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 33
States / cities: Mesa, Arizona • Phoenix, Arizona • Castro Valley, California + 25 more

Search by objective public record fields.

Bioburden Reduction of Diabetic Foot Ulcer

Nerve Decompression for Ulcer Recurrence Avoidance (DURA)

DermACELL in Subjects With Chronic Wounds of the Lower Extremities

PuraPly™ Antimicrobial Wound Matrix and Wound Management

GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers

Adapting Lifestyle Offloading for DFUs

SDRM® vs. Collagen for Diabetic Foot Ulcers

Differential Characteristics of Neuropathy in Type 2 Diabetics With and Without Lower Extremity Wounds

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers

GrafixPL PRIME Evaluation Case Study

Omega3 Wound Fish Skin Graft in the Treatment of DFUs

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics

Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Placental Cells for Diabetic Foot Ulcers

Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers

TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence

Novel Offloading for Diabetic Foot Ulcers With PulseFlow: A Prospective Study

Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients

Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers